|4Jun 10, 11:32 AM ET

Jene Jill M. 4

4 · Lipocine Inc. · Filed Jun 10, 2022

Insider Transaction Report

Form 4
Period: 2022-06-08
Jene Jill M.
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-06-08$0.92/sh+22,000$20,24032,000 total
    Exercise: $0.92From: 2023-06-08Exp: 2032-06-08Common Stock (22,000 underlying)
Footnotes (1)
  • [F1](1) 100% vesting one year from date of grant.

Documents

1 file
  • 4
    ownership.xmlPrimary